The pharmaceutical industry is facing both external and internal challenges. The external challenges are a lot about the health care sector’s strong focus on costs and lack of resources, creating a tough market to operate on. The internal challenges are especially about the need to be better at creating a dialogue with the new stakeholders. And LIF, the trade association for the research-based pharmaceutical industry in Sweden, needs to work on strengthening the industry’s reputation. These are some of the main findings of the survey that Opticom conducts each year in collaboration with the Pharma Industry magazine and LIF.
Since 2010, Opticom conducts an annual industry survey in the Swedish pharmaceutical industry in collaboration with Pharma Industry, and since 2012 also with LIF. The study is meant to reflect major industry issues and show how attitudes change over time. The study is designed as a web survey among Pharma Industry’s readers and other relevant people in the industry. This year’s survey was conducted in the spring of 2013.
Click here to read the full article about this survey on the pharmaceutical industry (in Swedish).
Nine out of ten Swedes think it is very important to keep research in pharmaceutical companies in Sweden. A majority of citizens is willing to pay more to get access to new and modern pharmaceuticals. At the same time, the industry thinks the biggest threat to the industry is the lack of willingness to pay for innovative pharmaceuticals. This is one of many interesting results which appear in a new survey on the pharmaceutical industry. Continue reading
The pharmaceutical industry does not get the appreciation, respect or financial compensation it deserves. Health care providers are perceived as adversaries rather than partners and there are no natural possibilities to obtain access to the final customer. These are some of the conclusions from the industry survey that the industry journal Pharma Industry, and Opticom, conducted for the second consecutive year. The survey includes answers from 173 respondents representing 57 different pharmaceutical companies active in Sweden. Continue reading
Today Opticom launches the first comprehensive report about the market situation following the re-regulation of the Swedish pharmacy market. The report is based on results from in-depth interviews with leading executives at pharmacy companies, a survey among representatives for the pharmaceutical industry as well as an analysis of published market research about customers’ satisfaction with pharmacies. Continue reading
A recent market study on the pharmaceutical industry’s views on the pharmacy market shows that several pharmaceutical companies want to develop their cooperation with pharmacies. Continue reading